Myriad Genetics, Inc. (MYGN)
3.97
-0.25
(-5.92%)
USD |
NASDAQ |
May 29, 16:00
4.00
+0.03
(+0.76%)
After-Hours: 20:00
Myriad Genetics Market Cap : 374.96M for May 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 31.99B |
| BioRestorative Therapies, Inc. | 12.18M |
| CareDx, Inc. | 1.179B |
| Exagen, Inc. | 120.32M |
| Sera Prognostics, Inc. | 84.58M |
Market Cap Related Metrics
| PS Ratio | 0.4461 |
| PEG Ratio | -0.0032 |
| Price to Book Value | 1.111 |
| Price | 3.97 |
| Earnings Yield | -108.7% |
| PEGY Ratio | -0.0032 |